# McKesson (MCK) — Analyst Forecast

MCK · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/mck/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 15 | 5 | 0 | 20 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $845.00 | $991.75 | $1,080.00 | 8 |

Last price $998.64 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 7, 2026 | Leerink Partners | Maintained | Outperform | $1,070.00 |
| Sep 14, 2026 | RBC Capital | Maintained | Sector Perform | $845.00 |
| Aug 19, 2026 | Barclays | Maintained | Overweight | $1,000.00 |
| Aug 19, 2026 | RBC Capital | Initiated Coverage | Sector Perform | $845.00 |
| Aug 11, 2026 | Wells Fargo | Maintained | Equal-Weight | $933.00 |
| Aug 6, 2026 | Evercore ISI Group | Maintained | Outperform | $1,000.00 |
| Aug 6, 2026 | UBS | Maintained | Buy | $1,080.00 |
| Aug 6, 2026 | TD Cowen | Maintained | Buy | $1,006.00 |
| Jul 24, 2026 | Citigroup | Maintained | Buy | $1,000.00 |
| Jul 21, 2026 | TD Cowen | Maintained | Buy | $989.00 |
| Jun 10, 2026 | Barclays | Maintained | Overweight | $925.00 |
| May 14, 2026 | Citigroup | Maintained | Buy | $945.00 |
| May 12, 2026 | Wells Fargo | Maintained | Equal-Weight | $812.00 |
| May 8, 2026 | Evercore ISI Group | Maintained | Outperform | $850.00 |
| May 8, 2026 | JP Morgan | Maintained | Overweight | $1,015.00 |
| May 8, 2026 | UBS | Maintained | Buy | $1,050.00 |
| Apr 28, 2026 | William Blair | Initiated Coverage | Outperform | — |
| Apr 22, 2026 | UBS | Maintained | Buy | $1,000.00 |
| Apr 8, 2026 | Evercore ISI Group | Maintained | Outperform | $950.00 |
| Apr 6, 2026 | B of A Securities | Maintained | Buy | $1,000.00 |

## Frequently Asked Questions

### What is the price target for MCK stock?

The average 12-month analyst price target for McKesson (MCK) is $991.75, with a high estimate of $1,080.00 and a low of $845.00, across 8 analysts.

### Is MCK a buy, sell, or hold?

Analysts covering McKesson currently average a Buy rating: 15 buy, 5 hold and 0 sell, from 20 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for MCK?

The average price target of $991.75 implies 0.69% downside from the last price of $998.64.

### What is the latest analyst rating on MCK?

On Oct 7, 2026, Leerink Partners maintained McKesson at Outperform with a price target of $1,070.00.

## Similar Stocks

- [AMN](https://www.lighthorse.io/tickers/amn) — AMN Healthcare Services Inc
- [HSIC](https://www.lighthorse.io/tickers/hsic) — Henry Schein, Inc. - Common Stock
- [BIO](https://www.lighthorse.io/tickers/bio) — Bio-Rad Laboratories, Inc. Class A Common Stock
- [HQY](https://www.lighthorse.io/tickers/hqy) — HealthEquity, Inc. - Common Stock
- [ITGR](https://www.lighthorse.io/tickers/itgr) — Integer Holdings Corporation Common Stock
- [WST](https://www.lighthorse.io/tickers/wst) — West Pharmaceutical Services, Inc. Common Stock
- [MMSI](https://www.lighthorse.io/tickers/mmsi) — Merit Medical Systems, Inc. - Common Stock
- [HUM](https://www.lighthorse.io/tickers/hum) — Humana Inc. Common Stock
- [CRL](https://www.lighthorse.io/tickers/crl) — Charles River Laboratories International, Inc. Common Stock
- [NEOG](https://www.lighthorse.io/tickers/neog) — Neogen Corporation - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).